“Generation of recombinant hyperimmune globulins from diverse B-cell repertoires” publication in Nature Biotechnology

“Generation of recombinant hyperimmune globulins from diverse B-cell repertoires” publication in Nature Biotechnology

Congratulations to Alira Health’s Steven Chamow, Senior Vice President, CMC and founder of Chamow & Associates, and to Bryan Monroe and Chuck Olson, Senior Consultants, on their contributions to “Generation of recombinant hyperimmune globulins from diverse B-cell repertoires” published in Nature Biotechnology.

The publication by Sheila Keating, Rena Mizrahi, and colleagues is a result of a large collaborative effort organized and coordinated by GigaGen Inc., a US biotechnology company specializing in the discovery and development of recombinant biotherapeutic medicines. It describes a microfluidics and molecular genomics strategy for capturing diverse mammalian antibody repertoires to create recombinant multivalent antibodies.

To learn more about this novel method and to read the full publication, click here: https://lnkd.in/eK25Zpx

Close Menu